Multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.

We present the first detailed study using multispectral multiphoton fluorescence lifetime imaging to differentiate basal cell carcinoma cells (BCCs) from normal keratinocytes. Images were acquired from 19 freshly excised BCCs and 27 samples of normal skin (in & ex vivo). Features from fluorescen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rakesh Patalay, Clifford Talbot, Yuriy Alexandrov, Martin O Lenz, Sunil Kumar, Sean Warren, Ian Munro, Mark A A Neil, Karsten König, Paul M W French, Anthony Chu, Gordon W H Stamp, Chris Dunsby
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e071b863a76543ada35f00f76c25e195
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e071b863a76543ada35f00f76c25e195
record_format dspace
spelling oai:doaj.org-article:e071b863a76543ada35f00f76c25e1952021-11-18T07:06:07ZMultiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.1932-620310.1371/journal.pone.0043460https://doaj.org/article/e071b863a76543ada35f00f76c25e1952012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22984428/?tool=EBIhttps://doaj.org/toc/1932-6203We present the first detailed study using multispectral multiphoton fluorescence lifetime imaging to differentiate basal cell carcinoma cells (BCCs) from normal keratinocytes. Images were acquired from 19 freshly excised BCCs and 27 samples of normal skin (in & ex vivo). Features from fluorescence lifetime images were used to discriminate BCCs with a sensitivity/specificity of 79%/93% respectively. A mosaic of BCC fluorescence lifetime images covering >1 mm(2) is also presented, demonstrating the potential for tumour margin delineation. Using 10,462 manually segmented cells from the image data, we quantify the cellular morphology and spectroscopic differences between BCCs and normal skin for the first time. Statistically significant increases were found in the fluorescence lifetimes of cells from BCCs in all spectral channels, ranging from 19.9% (425-515 nm spectral emission) to 39.8% (620-655 nm emission). A discriminant analysis based diagnostic algorithm allowed the fraction of cells classified as malignant to be calculated for each patient. This yielded a receiver operator characteristic area under the curve for the detection of BCC of 0.83. We have used both morphological and spectroscopic parameters to discriminate BCC from normal skin, and provide a comprehensive base for how this technique could be used for BCC assessment in clinical practice.Rakesh PatalayClifford TalbotYuriy AlexandrovMartin O LenzSunil KumarSean WarrenIan MunroMark A A NeilKarsten KönigPaul M W FrenchAnthony ChuGordon W H StampChris DunsbyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e43460 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rakesh Patalay
Clifford Talbot
Yuriy Alexandrov
Martin O Lenz
Sunil Kumar
Sean Warren
Ian Munro
Mark A A Neil
Karsten König
Paul M W French
Anthony Chu
Gordon W H Stamp
Chris Dunsby
Multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.
description We present the first detailed study using multispectral multiphoton fluorescence lifetime imaging to differentiate basal cell carcinoma cells (BCCs) from normal keratinocytes. Images were acquired from 19 freshly excised BCCs and 27 samples of normal skin (in & ex vivo). Features from fluorescence lifetime images were used to discriminate BCCs with a sensitivity/specificity of 79%/93% respectively. A mosaic of BCC fluorescence lifetime images covering >1 mm(2) is also presented, demonstrating the potential for tumour margin delineation. Using 10,462 manually segmented cells from the image data, we quantify the cellular morphology and spectroscopic differences between BCCs and normal skin for the first time. Statistically significant increases were found in the fluorescence lifetimes of cells from BCCs in all spectral channels, ranging from 19.9% (425-515 nm spectral emission) to 39.8% (620-655 nm emission). A discriminant analysis based diagnostic algorithm allowed the fraction of cells classified as malignant to be calculated for each patient. This yielded a receiver operator characteristic area under the curve for the detection of BCC of 0.83. We have used both morphological and spectroscopic parameters to discriminate BCC from normal skin, and provide a comprehensive base for how this technique could be used for BCC assessment in clinical practice.
format article
author Rakesh Patalay
Clifford Talbot
Yuriy Alexandrov
Martin O Lenz
Sunil Kumar
Sean Warren
Ian Munro
Mark A A Neil
Karsten König
Paul M W French
Anthony Chu
Gordon W H Stamp
Chris Dunsby
author_facet Rakesh Patalay
Clifford Talbot
Yuriy Alexandrov
Martin O Lenz
Sunil Kumar
Sean Warren
Ian Munro
Mark A A Neil
Karsten König
Paul M W French
Anthony Chu
Gordon W H Stamp
Chris Dunsby
author_sort Rakesh Patalay
title Multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.
title_short Multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.
title_full Multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.
title_fullStr Multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.
title_full_unstemmed Multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.
title_sort multiphoton multispectral fluorescence lifetime tomography for the evaluation of basal cell carcinomas.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/e071b863a76543ada35f00f76c25e195
work_keys_str_mv AT rakeshpatalay multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT cliffordtalbot multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT yuriyalexandrov multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT martinolenz multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT sunilkumar multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT seanwarren multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT ianmunro multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT markaaneil multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT karstenkonig multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT paulmwfrench multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT anthonychu multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT gordonwhstamp multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
AT chrisdunsby multiphotonmultispectralfluorescencelifetimetomographyfortheevaluationofbasalcellcarcinomas
_version_ 1718423949251969024